Envestnet Asset Management
HRMY icon

Envestnet Asset Management’s Harmony Biosciences HRMY Stock Holding History

Envestnet Asset Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.96M Buy
53,937
+2,151
+4% +$67.9K ﹤0.01% 3173
2026
Q1 		$1.45M Buy
51,786
+11,234
+28% +$368K ﹤0.01% 3234
2025
Q4 		$1.52M Sell
40,552
-1,635
-4% -$53.8K ﹤0.01% 3030
2025
Q3 		$1.16M Sell
42,187
-198
-0.5% -$6.82K ﹤0.01% 3244
2025
Q2 		$1.34M Sell
42,385
-15,944
-27% -$513K ﹤0.01% 3083
2025
Q1 		$1.94M Buy
58,329
+4,503
+8% +$161K ﹤0.01% 2759
2024
Q4 		$1.85M Buy
53,826
+1,321
+3% +$45.4K ﹤0.01% 2739
2024
Q3 		$2.1M Sell
52,505
-8,892
-14% -$312K ﹤0.01% 2618
2024
Q2 		$1.85M Buy
61,397
+10,167
+20% +$306K ﹤0.01% 2647
2024
Q1 		$1.72M Buy
+51,230
New +$1.64M ﹤0.01% 2673
2023
Q3 		– Sell
-27,032
Closed -$951K – 4082
2023
Q2 		$951K Sell
27,032
-172,162
-86% -$5.94M ﹤0.01% 2784
2023
Q1 		$867K Buy
199,194
+173,036
+662% +$7.88M ﹤0.01% 2773
2022
Q4 		$1.44M Buy
26,158
+14,179
+118% +$780K ﹤0.01% 2387
2022
Q3 		$531K Buy
11,979
+5,448
+83% +$266K ﹤0.01% 2987
2022
Q2 		$319K Buy
+6,531
New +$294K ﹤0.01% 3320

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Envestnet Asset Management's HRMY Position: Q2 2026 in Review

Envestnet Asset Management increased its Harmony Biosciences (HRMY) stake by 4.2% in Q2 2026, buying an estimated $67.9K and bringing the position to 53,937 shares worth $1.96M. The position accounts for ﹤0.01% of the portfolio, ranked #3173.

Envestnet Asset Management first reported a position in HRMY in Q2 2022 and has held it in 15 quarters since. The position peaked at $2.1M in Q3 2024. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Envestnet Asset Management held 53,937 shares of Harmony Biosciences worth $1.96M as of Q2 2026.
  • Envestnet Asset Management bought 2,151 Harmony Biosciences shares in Q2 2026, an estimated $67.9K.
  • Harmony Biosciences made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #3173 holding.
  • Envestnet Asset Management first reported a position in Harmony Biosciences in Q2 2022 and has held it in 15 quarters since.
  • Envestnet Asset Management's Harmony Biosciences position peaked at $2.1M in Q3 2024.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.